Eli Lilly and Company today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound ...

India, May 10 -- Heartburn and heart attack may feel the same and it is difficult for even an experienced doctor to ...

Medications known as GLP-1 drugs, such as Ozempic, Wegovy, and more have become increasingly popular for weight loss and ...

Severe acute pancreatitis (SAP) remains one of the most formidable challenges in gastrointestinal emergency medicine.

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant ...

What started as a drug to treat type 2 diabetes has quickly become one of the most popular weight loss trends in the country. Police searching for two suspects in shooting death of Martinsville woman ...

CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious acute ...

In this guide, learn the eligibility criteria for brand-name semaglutide, cost and insurance coverage, safety risks of compounded semaglutide and how to find a reputable telehealth provider online.

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

Unexpected bowel benefits: Patients with IBD and obesity on GLP-1 therapy plus lifestyle counseling reported improved bowel symptoms, contrary to common concerns about gastrointestinal side effects.